A circRNA signature predicts postoperative recurrence in stage II/III colon cancer.

EMBO Mol Med · 2019 · PMC6783650 · PMID 31475771

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

extremely significantP < 0.01actually significant

Among these candidates, 22 circRNAs (10 from TNcircles and 12 from RNcircles) were further selected based on the extremely significant difference ( P < 0.01; Figs 2 C and EV1 ).

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.